HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gloria Sovena Selected Research

HLA-DR Antigens (HLA-DR)

9/2006Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gloria Sovena Research Topics

Disease

5Melanoma (Melanoma, Malignant)
12/2012 - 05/2004
4Neoplasms (Cancer)
12/2012 - 05/2005
1Neoplasm Metastasis (Metastasis)
05/2005
1Colorectal Neoplasms (Colorectal Cancer)
05/2005
1Adenocarcinoma
05/2004

Drug/Important Bio-Agent (IBA)

4Peptides (Polypeptides)IBA
12/2012 - 05/2004
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2006 - 05/2004
2AntigensIBA
08/2006 - 05/2006
2MART-1 AntigenIBA
05/2006 - 05/2004
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2012
1Cancer VaccinesIBA
12/2012
1Transforming Growth Factor beta (TGF-beta)IBA
09/2006
1HLA-DR Antigens (HLA-DR)IBA
09/2006
1InterleukinsIBA
09/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2006
1EnzymesIBA
08/2006
1vitespinIBA
08/2006
1VaccinesIBA
08/2006
1Interferon-alpha (Interferon Alfa)IBA
08/2006
1Fluorescein-5-isothiocyanate (FITC)IBA
05/2005
1CytokinesIBA
05/2005
1sarcoma glycoprotein gp96 rejection antigensIBA
05/2005
1HLA-A*02:01 antigenIBA
05/2004

Therapy/Procedure

1Therapeutics
12/2012